InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Hunt Nimrata, Chief Executive Officer. Director active across 2 companies, notably Idexx Laboratories INC /de. Cumulatively, 7 disclosures have been published. The latest transaction was disclosed on 1 June 2022 — Levée d'options. Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
0254 shares0
Class A Common Stock
SEC:0001628280-22-016105:0·
0169 shares0
Class A Common Stock
SEC:0001628280-22-005001:0·
088 shares0
Common Stock
SEC:0001567619-22-004781:0·
€44,507769 shares@ €57.8760.0001% mcap96.6% of flow
Common Stock
SEC:0001567619-21-015280·
€44,507769 shares@ €57.8760.0001% mcap48.3% of flow
Common Stock
SEC:0001567619-21-015280:0·
€1,54827 shares@ €57.32650.0000% mcap3.4% of flow
Common Stock
SEC:0001567619-21-014768·
€1,54827 shares@ €57.32650.0000% mcap1.7% of flow
Common Stock
SEC:0001567619-21-014768:0·
7 of 7 declarations
About Hunt Nimrata
Hunt Nimrata serves as CEO at IDEXX Laboratories Inc and Veeva Systems Inc. She oversees the operations of the companies and is responsible for overall strategy. Her leadership is essential for guiding the companies towards success and growth.
